Eurofins Scientific SE
XBER:ESF0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Eurofins Scientific SE
XBER:ESF0
|
LU |
|
Cineverse Corp
NASDAQ:CNVS
|
US |
|
Zehnder Group AG
LSE:0R6S
|
CH |
|
G
|
Gentex Corp
XMUN:GTX
|
US |
|
Eterna Therapeutics Inc
NASDAQ:ERNA
|
US |
Wall St Price Targets
ESF0 Price Targets Summary
Eurofins Scientific SE
According to Wall Street analysts, the average 1-year price target for ESF0 is 67.07 EUR with a low forecast of 45.22 EUR and a high forecast of 84.23 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ESF0's stock price target?
Price Target
67.07
EUR
According to Wall Street analysts, the average 1-year price target for ESF0 is 67.07 EUR with a low forecast of 45.22 EUR and a high forecast of 84.23 EUR.
What is the Revenue forecast for Eurofins Scientific SE?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 5 years is 8%.
What is the Gross Profit forecast for Eurofins Scientific SE?
Projected CAGR
36%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 5 years is 36%.
What is the Operating Income forecast for Eurofins Scientific SE?
Projected CAGR
19%
Over the last 14 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 5 years is 19%.
What is the Pre-Tax Income forecast for Eurofins Scientific SE?
Projected CAGR
24%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 15%. The projected CAGR for the next 3 years is 24%.
What is the Net Income forecast for Eurofins Scientific SE?
Projected CAGR
28%
Over the last 14 years, the compound annual growth rate for Net Income has been 17%. The projected CAGR for the next 5 years is 28%.
